Annual Cash & Cash Equivalents
$53.50 M
-$49.03 M-47.82%
December 1, 2023
Summary
- As of February 8, 2025, ARTV annual cash & cash equivalents is $53.50 million, with the most recent change of -$49.03 million (-47.82%) on December 1, 2023.
- During the last 3 years, ARTV annual cash & cash equivalents has risen by +$28.06 million (+110.30%).
- ARTV annual cash & cash equivalents is now -66.75% below its all-time high of $160.92 million, reached on December 1, 2021.
Performance
ARTV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$55.88 M
+$21.63 M+63.17%
September 1, 2024
Summary
- As of February 8, 2025, ARTV quarterly cash and cash equivalents is $55.88 million, with the most recent change of +$21.63 million (+63.17%) on September 1, 2024.
- ARTV quarterly cash and cash equivalents is now -66.97% below its all-time high of $169.19 million, reached on September 1, 2021.
Performance
ARTV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ARTV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.8% | - |
| 3 y3 years | +110.3% | - |
| 5 y5 years | +2758.1% | - |
ARTV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.8% | at low | -65.3% | +63.2% |
| 5 y | 5-year | -66.8% | +2758.1% | -67.0% | +119.6% |
| alltime | all time | -66.8% | +2758.1% | -67.0% | +119.6% |
Artiva Biotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $55.88 M(+63.2%) |
| Jun 2024 | - | $34.25 M(-28.9%) |
| Mar 2024 | - | $48.20 M(-9.9%) |
| Dec 2023 | $53.50 M(-47.8%) | $53.50 M(-64.4%) |
| Dec 2022 | $102.53 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $150.35 M(-6.6%) |
| Dec 2021 | $160.92 M(+532.5%) | $160.92 M(-4.9%) |
| Sep 2021 | - | $169.19 M(+565.0%) |
| Dec 2020 | $25.44 M(+1259.1%) | $25.44 M |
| Dec 2019 | $1.87 M | - |
FAQ
- What is Artiva Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Artiva Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Artiva Biotherapeutics?
What is Artiva Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ARTV is $53.50 M
What is the all time high annual cash & cash equivalents for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high annual cash & cash equivalents is $160.92 M
What is Artiva Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ARTV annual cash & cash equivalents has changed by -$49.03 M (-47.82%)
What is Artiva Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARTV is $55.88 M
What is the all time high quarterly cash and cash equivalents for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high quarterly cash and cash equivalents is $169.19 M